Texas Bank & Trust’s AbbVie ABBV Stock Holding History

Texas Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$875K	Sell	4,021 -926	-19%	-$205K	0.33%	81
2025 Q4	$1.13M	Sell	4,947 -55	-1%	-$12.5K	0.41%	63
2025 Q3	$1.16M	Buy	5,002 +509	+11%	+$104K	0.44%	61
2025 Q2	$834K	Sell	4,493 -1,896	-30%	-$352K	0.33%	83
2025 Q1	$1.34M	Buy	6,389 +47	+0.7%	+$9.14K	0.57%	44
2024 Q4	$1.13M	Buy	+6,342	New	+$1.17M	0.46%	57

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Texas Bank & Trust's ABBV Position: Q1 2026 in Review

Texas Bank & Trust reduced its AbbVie (ABBV) stake by 19% in Q1 2026, selling an estimated $205K and leaving 4,021 shares worth $875K. The position accounts for 0.33% of the portfolio, ranked #81.

Texas Bank & Trust first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.34M in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Texas Bank & Trust held 4,021 shares of AbbVie worth $875K as of Q1 2026.
Texas Bank & Trust sold 926 AbbVie shares in Q1 2026, an estimated $205K.
AbbVie made up 0.33% of Texas Bank & Trust's portfolio in Q1 2026, its #81 holding.
Texas Bank & Trust first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Texas Bank & Trust's AbbVie position peaked at $1.34M in Q1 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.